AdaptIV Infusion Company Profile

Background

Overview

AdaptIV Infusion is an ambulatory infusion clinic specializing in intravenous and injection therapies for patients with autoimmune disorders and complex chronic conditions. Established in 2022, the clinic is located in Sugar Land, Texas, serving the Greater Houston area. The facility offers a range of treatments, including biologics, immunoglobulin therapy (IVIG), antibiotics, vitamins, minerals, and other specialty medications.

Mission and Vision

AdaptIV Infusion is dedicated to reimagining infusion care by focusing on the patient experience. The clinic aims to provide best-in-class clinical care and affordable access to therapies in a comfortable setting, close to home, and outside of the hospital environment.

Primary Area of Focus

The clinic's primary focus is on delivering infusion therapies for conditions such as gout, Crohn's disease, multiple sclerosis, rheumatoid arthritis, thyroid eye disease, and psoriasis. By partnering with specialty physicians in neurology, gastroenterology, rheumatology, ophthalmology, and immunology, AdaptIV Infusion ensures comprehensive care for its patients.

Industry Significance

AdaptIV Infusion operates within the ambulatory infusion therapy market, which is experiencing significant growth. The market was valued at approximately $3.25 billion in 2024 and is projected to reach $6.12 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period (2025–2032). This growth is driven by the increasing prevalence of chronic diseases and the shift towards outpatient care settings.

Key Strategic Focus

Core Objectives

Patient-Centered Care: Prioritizing the comfort and well-being of patients during treatment sessions.

Accessibility: Ensuring treatments are available in convenient, close-to-home locations.

Affordability: Working with patients to access financial assistance programs and offering cost-effective solutions.

Areas of Specialization

Infusion Therapies: Administering FDA-approved treatments for chronic autoimmune disorders.

Patient Support Services: Assisting with insurance verification, prior authorizations, and financial assistance.

Key Technologies Utilized

Electronic Health Records (EHR): For efficient patient data management.

Telehealth Integration: To enhance patient engagement and follow-up care.

Patient Management Systems: Streamlining appointment scheduling and treatment tracking.

Primary Markets Targeted

Geographic Focus: Residents of Sugar Land, Richmond, Rosenberg, Missouri City, Stafford, and the surrounding Fort Bend and Greater Houston areas.

Patient Demographics: Individuals with chronic autoimmune disorders and complex chronic conditions.

Financials and Funding

Funding History

As a privately held entity, specific details regarding AdaptIV Infusion's funding history are not publicly disclosed. The clinic's operations are supported through private investments and revenue generated from patient services.

Utilization of Capital

The capital is primarily utilized for:

Facility Operations: Maintaining and upgrading the state-of-the-art clinic.

Patient Care Services: Ensuring high-quality infusion therapies and support services.

Community Outreach: Educating the public about available treatments and services.

Pipeline Development

Pipeline Candidates

AdaptIV Infusion offers a comprehensive range of infusion therapies, including:

Biologics: Targeted treatments for autoimmune disorders.

IVIG: Immunoglobulin therapy for immune system support.

Antibiotics: For infections requiring intravenous administration.

Vitamins and Minerals: To address deficiencies in patients.

Stages of Development

The clinic focuses on the administration of existing FDA-approved therapies rather than developing new pipeline candidates.

Target Conditions

Autoimmune Disorders: Such as rheumatoid arthritis and Crohn's disease.

Chronic Conditions: Including multiple sclerosis and psoriasis.

Anticipated Milestones

Expansion Plans: Potential opening of additional clinics in the Greater Houston area to increase accessibility.

Service Enhancements: Introduction of new therapies and patient support programs based on emerging medical research.

Technological Platform and Innovation

Proprietary Technologies

AdaptIV Infusion utilizes advanced patient management systems to streamline operations and enhance the patient experience. These systems facilitate efficient scheduling, treatment tracking, and communication between patients and healthcare providers.

Significant Scientific Methods

The clinic employs evidence-based protocols for administering infusion therapies, ensuring treatments are aligned with the latest clinical guidelines and research findings.

Leadership Team

Executive Profiles

Shareef Defrawi – Chief Executive Officer: With extensive experience in healthcare management, Shareef leads the strategic direction of AdaptIV Infusion, focusing on patient-centered care and operational excellence.

Aylin Poulton – Managing Partner: Aylin oversees the clinic's operations, emphasizing financial management, patient services, and community engagement.

Lindsay Kem – Infusion Practice Administrator: Lindsay manages the day-to-day clinical operations, ensuring high standards of care and patient safety.

Bridget Kress – Account Executive: Bridget is responsible for business development, building relationships with referring physicians, and expanding the clinic's network.

Kylar Martin – Administrative Assistant: Kylar supports administrative functions, including scheduling, patient communications, and office management.

Competitor Profile

Market Insights and Dynamics

The ambulatory infusion therapy market is characterized by a growing demand for outpatient services, driven by the increasing prevalence of chronic diseases and the shift towards cost-effective care settings. North America holds a significant share of the market, with the United States leading due to advanced healthcare infrastructure and favorable reimbursement policies.

Competitor Analysis

Key competitors in the ambulatory infusion therapy market include:

Option Care Health: The largest independent provider with over 175 infusion suites across 45 states, offering a wide range of infusion therapies.

CVS Health (Coram): Leverages its extensive retail footprint to provide infusion services, integrating them with its MinuteClinic network.

Fresenius Kabi: A global healthcare company offering infusion therapies and services, with a strong presence in the outpatient care sector.

Strategic Collaborations and Partnerships

AdaptIV Infusion collaborates with specialty physicians in various fields to offer comprehensive care. These partnerships enhance the clinic's ability to provide specialized treatments and improve patient outcomes.

Operational Insights

AdaptIV Infusion differentiates itself through its patient-centered approach, focusing on comfort, accessibility, and affordability. The clinic's state-of-the-art facility and personalized services set it apart from traditional hospital-based infusion centers.

Strategic Opportunities and Future Directions